Loading…

Tissue‐Selective Effects of Injected Deoxycholate

BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially targ...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic surgery 2010-06, Vol.36 (6), p.899-908
Main Authors: THUANGTONG, RATTAPON, BENTOW, JASON J., KNOPP, KRISTEENE, MAHMOOD, NADIR A., DAVID, NATHANIEL E., KOLODNEY, MICHAEL S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383
cites cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383
container_end_page 908
container_issue 6
container_start_page 899
container_title Dermatologic surgery
container_volume 36
creator THUANGTONG, RATTAPON
BENTOW, JASON J.
KNOPP, KRISTEENE
MAHMOOD, NADIR A.
DAVID, NATHANIEL E.
KOLODNEY, MICHAEL S.
description BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat. OBJECTIVE To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models. METHODS AND MATERIALS  Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity. RESULTS  In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans. CONCLUSION  We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC. This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.
doi_str_mv 10.1111/j.1524-4725.2010.01566.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733962015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733962015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</originalsourceid><addsrcrecordid>eNqNkE9PwjAYhxujEUS_gtnFeBr2z9ptBw8GUElIPADnpmvfxi2D4coUbn4EP6OfxA4Qr_bSX94-79v2QSgguE_8uiv6hNMojGLK-xT7KiZciP7mBHWPB6c-41iEmBPaQRfOFRgTmjJ8jjoURwmNKesiNsuda-D782sKJeh1_g7ByFqfXFDZYLwsfAQTDKHabPVrVao1XKIzq0oHV4e9h-aPo9ngOZy8PI0HD5NQszQRIVAFPCKKcZZYSnHKjDZCG2wzk6mMJ9wIprQSYCNueNTWOU5JHPGEYZawHrrdz13V1VsDbi0XudNQlmoJVeNkzFgq_Pe5J5M9qevKuRqsXNX5QtVbSbBsjclCtmJkK0a2xuTOmNz41uvDJU22AHNs_FXkgZsDoJxWpa3VUufuj6MpJtGOu99zH3kJ238_QA6n8zaxH2rHhnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733962015</pqid></control><display><type>article</type><title>Tissue‐Selective Effects of Injected Deoxycholate</title><source>Wiley Online Library (Online service)</source><creator>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</creator><creatorcontrib>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</creatorcontrib><description>BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat. OBJECTIVE To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models. METHODS AND MATERIALS  Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity. RESULTS  In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans. CONCLUSION  We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC. This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1111/j.1524-4725.2010.01566.x</identifier><identifier>PMID: 20482723</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adipocytes - drug effects ; Animals ; Biological and medical sciences ; Cell Culture Techniques ; Cholagogues and Choleretics - administration &amp; dosage ; Cholagogues and Choleretics - pharmacology ; Deoxycholic Acid - administration &amp; dosage ; Deoxycholic Acid - pharmacology ; Dermatology ; Fibroblasts - drug effects ; Humans ; Injections, Subcutaneous ; Keratinocytes - drug effects ; Medical sciences ; Mice ; Mice, Obese ; Models, Animal ; Muscle Cells - drug effects ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Skin - drug effects ; Skin - metabolism ; Skin - pathology ; Skin plastic surgery ; Subcutaneous Fat - drug effects ; Subcutaneous Fat - metabolism ; Subcutaneous Fat - pathology ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><ispartof>Dermatologic surgery, 2010-06, Vol.36 (6), p.899-908</ispartof><rights>2010 by the American Society for Dermatologic Surgery, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</citedby><cites>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1524-4725.2010.01566.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1524-4725.2010.01566.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22901423$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20482723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>THUANGTONG, RATTAPON</creatorcontrib><creatorcontrib>BENTOW, JASON J.</creatorcontrib><creatorcontrib>KNOPP, KRISTEENE</creatorcontrib><creatorcontrib>MAHMOOD, NADIR A.</creatorcontrib><creatorcontrib>DAVID, NATHANIEL E.</creatorcontrib><creatorcontrib>KOLODNEY, MICHAEL S.</creatorcontrib><title>Tissue‐Selective Effects of Injected Deoxycholate</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat. OBJECTIVE To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models. METHODS AND MATERIALS  Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity. RESULTS  In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans. CONCLUSION  We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC. This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</description><subject>Adipocytes - drug effects</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Culture Techniques</subject><subject>Cholagogues and Choleretics - administration &amp; dosage</subject><subject>Cholagogues and Choleretics - pharmacology</subject><subject>Deoxycholic Acid - administration &amp; dosage</subject><subject>Deoxycholic Acid - pharmacology</subject><subject>Dermatology</subject><subject>Fibroblasts - drug effects</subject><subject>Humans</subject><subject>Injections, Subcutaneous</subject><subject>Keratinocytes - drug effects</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Obese</subject><subject>Models, Animal</subject><subject>Muscle Cells - drug effects</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Skin - drug effects</subject><subject>Skin - metabolism</subject><subject>Skin - pathology</subject><subject>Skin plastic surgery</subject><subject>Subcutaneous Fat - drug effects</subject><subject>Subcutaneous Fat - metabolism</subject><subject>Subcutaneous Fat - pathology</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkE9PwjAYhxujEUS_gtnFeBr2z9ptBw8GUElIPADnpmvfxi2D4coUbn4EP6OfxA4Qr_bSX94-79v2QSgguE_8uiv6hNMojGLK-xT7KiZciP7mBHWPB6c-41iEmBPaQRfOFRgTmjJ8jjoURwmNKesiNsuda-D782sKJeh1_g7ByFqfXFDZYLwsfAQTDKHabPVrVao1XKIzq0oHV4e9h-aPo9ngOZy8PI0HD5NQszQRIVAFPCKKcZZYSnHKjDZCG2wzk6mMJ9wIprQSYCNueNTWOU5JHPGEYZawHrrdz13V1VsDbi0XudNQlmoJVeNkzFgq_Pe5J5M9qevKuRqsXNX5QtVbSbBsjclCtmJkK0a2xuTOmNz41uvDJU22AHNs_FXkgZsDoJxWpa3VUufuj6MpJtGOu99zH3kJ238_QA6n8zaxH2rHhnQ</recordid><startdate>201006</startdate><enddate>201006</enddate><creator>THUANGTONG, RATTAPON</creator><creator>BENTOW, JASON J.</creator><creator>KNOPP, KRISTEENE</creator><creator>MAHMOOD, NADIR A.</creator><creator>DAVID, NATHANIEL E.</creator><creator>KOLODNEY, MICHAEL S.</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201006</creationdate><title>Tissue‐Selective Effects of Injected Deoxycholate</title><author>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adipocytes - drug effects</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Culture Techniques</topic><topic>Cholagogues and Choleretics - administration &amp; dosage</topic><topic>Cholagogues and Choleretics - pharmacology</topic><topic>Deoxycholic Acid - administration &amp; dosage</topic><topic>Deoxycholic Acid - pharmacology</topic><topic>Dermatology</topic><topic>Fibroblasts - drug effects</topic><topic>Humans</topic><topic>Injections, Subcutaneous</topic><topic>Keratinocytes - drug effects</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Obese</topic><topic>Models, Animal</topic><topic>Muscle Cells - drug effects</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Skin - drug effects</topic><topic>Skin - metabolism</topic><topic>Skin - pathology</topic><topic>Skin plastic surgery</topic><topic>Subcutaneous Fat - drug effects</topic><topic>Subcutaneous Fat - metabolism</topic><topic>Subcutaneous Fat - pathology</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>THUANGTONG, RATTAPON</creatorcontrib><creatorcontrib>BENTOW, JASON J.</creatorcontrib><creatorcontrib>KNOPP, KRISTEENE</creatorcontrib><creatorcontrib>MAHMOOD, NADIR A.</creatorcontrib><creatorcontrib>DAVID, NATHANIEL E.</creatorcontrib><creatorcontrib>KOLODNEY, MICHAEL S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>THUANGTONG, RATTAPON</au><au>BENTOW, JASON J.</au><au>KNOPP, KRISTEENE</au><au>MAHMOOD, NADIR A.</au><au>DAVID, NATHANIEL E.</au><au>KOLODNEY, MICHAEL S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tissue‐Selective Effects of Injected Deoxycholate</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2010-06</date><risdate>2010</risdate><volume>36</volume><issue>6</issue><spage>899</spage><epage>908</epage><pages>899-908</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat. OBJECTIVE To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models. METHODS AND MATERIALS  Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity. RESULTS  In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans. CONCLUSION  We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC. This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20482723</pmid><doi>10.1111/j.1524-4725.2010.01566.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-0512
ispartof Dermatologic surgery, 2010-06, Vol.36 (6), p.899-908
issn 1076-0512
1524-4725
language eng
recordid cdi_proquest_miscellaneous_733962015
source Wiley Online Library (Online service)
subjects Adipocytes - drug effects
Animals
Biological and medical sciences
Cell Culture Techniques
Cholagogues and Choleretics - administration & dosage
Cholagogues and Choleretics - pharmacology
Deoxycholic Acid - administration & dosage
Deoxycholic Acid - pharmacology
Dermatology
Fibroblasts - drug effects
Humans
Injections, Subcutaneous
Keratinocytes - drug effects
Medical sciences
Mice
Mice, Obese
Models, Animal
Muscle Cells - drug effects
Muscle, Skeletal - drug effects
Muscle, Skeletal - metabolism
Muscle, Skeletal - pathology
Skin - drug effects
Skin - metabolism
Skin - pathology
Skin plastic surgery
Subcutaneous Fat - drug effects
Subcutaneous Fat - metabolism
Subcutaneous Fat - pathology
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
title Tissue‐Selective Effects of Injected Deoxycholate
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A18%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tissue%E2%80%90Selective%20Effects%20of%20Injected%20Deoxycholate&rft.jtitle=Dermatologic%20surgery&rft.au=THUANGTONG,%20RATTAPON&rft.date=2010-06&rft.volume=36&rft.issue=6&rft.spage=899&rft.epage=908&rft.pages=899-908&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1111/j.1524-4725.2010.01566.x&rft_dat=%3Cproquest_cross%3E733962015%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733962015&rft_id=info:pmid/20482723&rfr_iscdi=true